Unknown

Dataset Information

0

Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.


ABSTRACT: Human matrix metalloproteinase-26 (MMP-26/endometase/matrilysin-2) is a putative biomarker for carcinomas of breast, prostate, and other cancers of epithelial origin. MMP-26 expression was silenced using small interfering RNA (siRNA) in the human breast cancer cell line MDA-MB-231. Immunological and proteomics approaches, including two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass spectrometry, were employed to identify differential protein expression in MMP-26 knockdown cells. A comparison of the protein expression profiles of control and MMP-26 knockdown cells revealed nine differentially regulated proteins. Five of the proteins (heat shock protein 90, glucose-regulated protein 78 (GRP78), annexin V, tropomyosin, and peroxiredoxin II) were up-regulated, while alpha-tubulin, cystatin SA-III, breast cancer metastasis suppressor 1 (BRMS1) and beta-actin were down-regulated. This decrease of BRMS1 expression is concomitant with an increase of invasion through matrix-coated membranes. These results suggest an important role for MMP-26 in the regulation of proteins involved in invasive and metastatic breast cancers.

SUBMITTER: Lee S 

PROVIDER: S-EPMC3069352 | biostudies-literature | 2011 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.

Lee Seakwoo S   Terry Doris D   Hurst Douglas R DR   Welch Danny R DR   Sang Qing-Xiang Amy QX  

Journal of Cancer 20110316


Human matrix metalloproteinase-26 (MMP-26/endometase/matrilysin-2) is a putative biomarker for carcinomas of breast, prostate, and other cancers of epithelial origin. MMP-26 expression was silenced using small interfering RNA (siRNA) in the human breast cancer cell line MDA-MB-231. Immunological and proteomics approaches, including two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization time-of-flight mass spectrometry, were employed to identify differential protein e  ...[more]

Similar Datasets

| S-ECPF-GEOD-45613 | biostudies-other
| S-EPMC10708952 | biostudies-literature
| S-EPMC7806519 | biostudies-literature
| S-EPMC6513092 | biostudies-literature
| S-ECPF-GEOD-11951 | biostudies-other
| S-ECPF-GEOD-56615 | biostudies-other
| S-EPMC7712503 | biostudies-literature
| S-EPMC5661475 | biostudies-literature
| S-EPMC3797219 | biostudies-literature
| S-EPMC7985374 | biostudies-literature